These insights underscore the need for further research on the therapeutic potential of ALD against PCa and inspired our investigation into its ability to trigger apoptosis in prostate cancer cells by disrupting AR signaling and other critical survival pathways. The gene discussed is AR; the disease is prostate carcinoma.